ooking into the eye of ADHD.

Phase 1

• Conditions: Adults with ADHD and suboptimal eye functioning.; MedDRA version: 16.1Level: LLTClassification code 10064104Term: ADHDSystem Organ Class: 100000004873; Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]

• Registration Number: EUCTR2013-005017-12-NL
• Lead Sponsor: Parnassia Bavo Groep - PsyQ

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-02-25
• Last Update Posted: 5 July 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Patient group and control group: Age 18 to 40 years old.
Patient group: Diagnosis of ADHD.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 150
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patient group and control group: Severe psychiatric comorbidity; substance abuse; contraindication for the intervention.
Control group: ADHD; use of stimulant medication.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified